Home About Our Services Experience Publications News & Events Contact Us Downloads

News Archives



Anne Kilburg, Joins RTI Health Solutions, Senior Director, Market Access and Outcomes Strategy
posted 2011.8.1

RESEARCH TRIANGLE PARK, NC - Anne Kilburg, MSc, a Market Access expert with more than 15 years of experience in pricing, health technology assessment, health economics and outcomes research in the pharmaceutical industry, joined RTI-Health Solutions (RTI-HS) as Senior Director in our Market Access and Outcomes Strategy Group in Europe. Anne is based in Weil am Rhein, just over the German border from Basel, Switzerland.

Anne brings expertise in the German Health Care Market as well as in the development of international pricing and market access strategies, health care policy and insight into individual health care systems, health technology assessment and health economics. She has led the design and management of health economic evaluations for major disease areas, including cardiovascular diseases, diabetes, immunosuppression, and infectious diseases.

In the last 10 years, Anne has held corporate senior positions in strategic pricing, market access and health economics at Novartis.

Previously she worked in health care strategic roles at Boston Scientific and at the Institute of Empirical Health Economics both based in Germany.

Anne Heyes, Head of Market Access, Europe said, "We are very excited that Anne Kilburg has joined our team. She adds extensive expertise and insight in providing successful solutions for market access issues internationally, and her expertise in the German health care system will prove a valuable resource for our clients."

Anne Kilburg holds a MSc in Human Nutrition Science and Economics from the University of Bonn, Germany. She has authored scientific papers and acted as an editor for the German journal Gesundheitsökonomie & Qualitätsmanagement.

About RTI Health Solutions

RTI Health Solutions provides scientifically rigorous research and consulting services in health economics, patient-reported outcomes, market access and outcomes strategy, health preference assessment, epidemiology, biostatistics, drug safety and pharmacovigilance to help biopharmaceutical companies successfully develop and gain market approval for their products.


Home | About | Our Services | Experience | Publications | News & Events | Contact Us | Downloads
©2008 RTI Health Solutions. All Rights Reserved.